0I3I Stock Overview
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
0I3I passed our risk checks.
The Cooper Companies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$90.96 |
| 52 Week High | US$103.95 |
| 52 Week Low | US$75.88 |
| Beta | 0.95 |
| 1 Month Change | -9.70% |
| 3 Month Change | -3.67% |
| 1 Year Change | -3.13% |
| 3 Year Change | -9.83% |
| 5 Year Change | 26.20% |
| Change since IPO | 48.16% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0I3I | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 1.2% | 2.1% | 2.3% |
| 1Y | -3.1% | -9.3% | 0.6% |
Return vs Industry: 0I3I exceeded the UK Medical Equipment industry which returned -8.5% over the past year.
Return vs Market: 0I3I underperformed the UK Market which returned 0.3% over the past year.
Price Volatility
| 0I3I volatility | |
|---|---|
| 0I3I Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0I3I has not had significant price volatility in the past 3 months.
Volatility Over Time: 0I3I's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 15,000 | Al White | www.coopercos.com |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
The Cooper Companies, Inc. Fundamentals Summary
| 0I3I fundamental statistics | |
|---|---|
| Market cap | US$18.22b |
| Earnings (TTM) | US$290.80m |
| Revenue (TTM) | US$3.67b |
61.6x
P/E Ratio4.9x
P/S RatioIs 0I3I overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0I3I income statement (TTM) | |
|---|---|
| Revenue | US$3.67b |
| Cost of Revenue | US$1.24b |
| Gross Profit | US$2.42b |
| Other Expenses | US$2.13b |
| Earnings | US$290.80m |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
May 30, 2024
| Earnings per share (EPS) | 1.46 |
| Gross Margin | 66.09% |
| Net Profit Margin | 7.93% |
| Debt/Equity Ratio | 36.0% |
How did 0I3I perform over the long term?
See historical performance and comparison